Just found what I think is your big 7. They start with google PE 25 and ends with NVIDIA PE 65. I cannot even guess what you see for similarities between these stocks and Lynas. If you pick one or two stocks and explain why you think they are relevant to Lynas I will be glad to discuss with you.
I will take NVIDA for an example of why I do not think they are at all relevant to LYC. AI is the hottest Market around and NIVDA dominates the processors to do AI. Lynas has less than 10% of REE oxides vs CCP 80%+ And the prices for that product have dropped from 1090 RMB /KG WV FEB 2022 to 361 today
In the last 8 Qs NVDA revenue has gone from 8,288 to 22,103 https://s201.q4cdn.com/141608511/files/doc_financials/2024/Q4FY24/Rev_by_Mkt_Qtrly_Trend_Q424.pdf.
during the same time Lynas has gone from AU$ 326M to 39M.
IN the last year NVDA profits have gone from US$ 512M to 1,536M https://s201.q4cdn.com/141608511/files/doc_financials/2024/q4/1cbe8fe7-e08a-46e3-8dcc-b429fc06c1a4.pdf
During that same time period Lynas's has gone from AU$ 150M to 39M.
So you can pick any one of your big 7 and show mw any similarities between Your Big 7 and Lynas. Only a fool would look at PEs and not look at history & current data to see if relates at all about what they are talking about.
Just to be clear NVDA is a hot stock in a hot sector. I have no idea when people will move onto the next hot thing it might be 1 to 2 years maybe even a max of 5 but when they do, all 7 of these stock will reflect much lower PEs. Lynas investors should be well aware of this effect, they lived through it and are continuing to see it deteriorate.
Have I explained why I find your big 7 question irrelevant? If not tell me where you see holes in my argument. Yes when Revenue and Profits are soring PE go up a lot. Do you think Lyas is soaring or are likely to go back to where they were any time in the next 2 years? if so Why?
- Forums
- ASX - By Stock
- LYC
- Ann: Half Year Report FY24 (including Annexure 4D)
LYC
lynas rare earths limited
Add to My Watchlist
3.48%
!
$8.88

Ann: Half Year Report FY24 (including Annexure 4D), page-71
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.88 |
Change
-0.320(3.48%) |
Mkt cap ! $8.306B |
Open | High | Low | Value | Volume |
$9.44 | $9.44 | $8.86 | $61.13M | 6.800M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 225 | $8.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.91 | 24100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 225 | 8.880 |
4 | 3190 | 8.850 |
3 | 14505 | 8.830 |
1 | 675 | 8.820 |
1 | 13997 | 8.810 |
Price($) | Vol. | No. |
---|---|---|
8.910 | 24100 | 1 |
8.920 | 2000 | 1 |
8.930 | 16197 | 3 |
8.940 | 3547 | 3 |
8.950 | 14197 | 2 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online